ESC 365 - ADEL: A population-based study of clinical outcomes of aldosterone dysregulation

ESC Professional Premium Access

ADEL: A population-based study of clinical outcomes of aldosterone dysregulation

Session: Late-Breaking Clinical Science: new treatments and biomarkers in hypertension

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor R. Thomsen (Aarhus, DK)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Reimar W Thomsen

Aarhus University, Aarhus (Denmark)

1 presentation

0 follower

3 more presentations in this session

Benefit-harm trade-offs of intensive blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of six pivotal randomized controlled trials.

Speaker: Doctor X. Guo (Shenyang, CN)

Duration of blood pressure treatment and risk of major cardiovascular events

Speaker: Professor K. Rahimi (Oxford, GB)

Sacubitril/Allisartan in hyperuricemia

Speaker: Doctor W. Zhang (Shanghai, CN)

Access the full session

Late-Breaking Clinical Science: new treatments and biomarkers in hypertension

Speakers: Professor R. Thomsen, Doctor X. Guo, Professor K. Rahimi, Doctor W. Zhang

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources